Inada-Inoue M - Search Results

1

A phase I study of binimetinib (MEK162) in Japanese patients with advanced solid tumors.

Watanabe K, Otsu S, Hirashima Y, Morinaga R, Nishikawa K, Hisamatsu Y, Shimokata T, Inada-Inoue M, Shibata T, Takeuchi H, Watanabe T, Tokushige K, Maacke H, Shiaro K, Ando Y. Watanabe K, et al. Among authors: inada inoue m. Cancer Chemother Pharmacol. 2016 Jun;77(6):1157-64. doi: 10.1007/s00280-016-3019-5. Epub 2016 Apr 12. Cancer Chemother Pharmacol. 2016. PMID: 27071922 Clinical Trial.

2

Association between bevacizumab-related hypertension and vascular endothelial growth factor (VEGF) gene polymorphisms in Japanese patients with metastatic colorectal cancer.

Morita S, Uehara K, Nakayama G, Shibata T, Oguri T, Inada-Inoue M, Shimokata T, Sugishita M, Mitsuma A, Ando Y. Morita S, et al. Cancer Chemother Pharmacol. 2013 Feb;71(2):405-11. doi: 10.1007/s00280-012-2028-2. Epub 2012 Nov 17. Cancer Chemother Pharmacol. 2013. PMID: 23161411

3

Phase 1 study of pazopanib alone or combined with lapatinib in Japanese patients with solid tumors.

Inada-Inoue M, Ando Y, Kawada K, Mitsuma A, Sawaki M, Yokoyama T, Sunakawa Y, Ishida H, Araki K, Yamashita K, Mizuno K, Nagashima F, Takekura A, Nagamatsu K, Sasaki Y. Inada-Inoue M, et al. Cancer Chemother Pharmacol. 2014 Apr;73(4):673-83. doi: 10.1007/s00280-014-2374-3. Epub 2014 Jan 24. Cancer Chemother Pharmacol. 2014. PMID: 24464355 Clinical Trial.

4

A phase I study of tasisulam sodium using an albumin-tailored dose in Japanese patients with advanced solid tumors.

Fujiwara Y, Ando Y, Mukohara T, Kiyota N, Chayahara N, Mitsuma A, Inada-Inoue M, Sawaki M, Ilaria R Jr, Kellie Turner P, Funai J, Maeda K, Minami H. Fujiwara Y, et al. Among authors: inada inoue m. Cancer Chemother Pharmacol. 2013 Apr;71(4):991-8. doi: 10.1007/s00280-013-2092-2. Epub 2013 Feb 1. Cancer Chemother Pharmacol. 2013. PMID: 23370664 Clinical Trial.

5

Phase I dose-escalation study of buparlisib (BKM120), an oral pan-class I PI3K inhibitor, in Japanese patients with advanced solid tumors.

Ando Y, Inada-Inoue M, Mitsuma A, Yoshino T, Ohtsu A, Suenaga N, Sato M, Kakizume T, Robson M, Quadt C, Doi T. Ando Y, et al. Among authors: inada inoue m. Cancer Sci. 2014 Mar;105(3):347-53. doi: 10.1111/cas.12350. Epub 2014 Feb 13. Cancer Sci. 2014. PMID: 24405565 Free PMC article. Clinical Trial.

6

Genetic polymorphisms associated with oxaliplatin-induced peripheral neurotoxicity in Japanese patients with colorectal cancer.

Oguri T, Mitsuma A, Inada-Inoue M, Morita S, Shibata T, Shimokata T, Sugishita M, Nakayama G, Uehara K, Hasegawa Y, Ando Y. Oguri T, et al. Among authors: inada inoue m. Int J Clin Pharmacol Ther. 2013 Jun;51(6):475-81. doi: 10.5414/CP201851. Int J Clin Pharmacol Ther. 2013. PMID: 23547850

7

Association between severe toxicity of nilotinib and UGT1A1 polymorphisms in Japanese patients with chronic myelogenous leukemia.

Shibata T, Minami Y, Mitsuma A, Morita S, Inada-Inoue M, Oguri T, Shimokata T, Sugishita M, Naoe T, Ando Y. Shibata T, et al. Among authors: inada inoue m. Int J Clin Oncol. 2014 Apr;19(2):391-6. doi: 10.1007/s10147-013-0562-5. Epub 2013 Apr 23. Int J Clin Oncol. 2014. PMID: 23609856

8

Pharmacogenetic association between GSTP1 genetic polymorphism and febrile neutropenia in Japanese patients with early breast cancer.

Sugishita M, Imai T, Kikumori T, Mitsuma A, Shimokata T, Shibata T, Morita S, Inada-Inoue M, Sawaki M, Hasegawa Y, Ando Y. Sugishita M, et al. Among authors: inada inoue m. Breast Cancer. 2016 Mar;23(2):195-201. doi: 10.1007/s12282-014-0547-x. Epub 2014 Jul 10. Breast Cancer. 2016. PMID: 25008867

9

Chemotherapy for biliary tract cancer: real-world experience in a single institute.

Maeda O, Ebata T, Shimokata T, Matsuoka A, Inada-Inoue M, Morita S, Takano Y, Urakawa H, Miyai Y, Sugishita M, Mitsuma A, Ando M, Mizuno T, Nagino M, Ando Y. Maeda O, et al. Among authors: inada inoue m. Nagoya J Med Sci. 2020 Nov;82(4):725-733. doi: 10.18999/nagjms.82.4.725. Nagoya J Med Sci. 2020. PMID: 33311803 Free PMC article.

10

Acute aortic dissection in a patient receiving multiple tyrosine kinase inhibitors for 5 years.

Funahashi Y, Sassa N, Inada-Inoue M, Ando Y, Matsukawa Y, Gotoh M. Funahashi Y, et al. Among authors: inada inoue m. Aktuelle Urol. 2014 Mar;45(2):132-4. doi: 10.1055/s-0033-1363274. Epub 2014 Apr 3. Aktuelle Urol. 2014. PMID: 24700069

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page